Biofilm formation is increasingly recognized as the cause of persistent infections and there is evidence that P. aeruginosa organized into biofilms are quite resistant toward host defence mechanisms, particularly against an attack by polymorphonuclear neutrophils (PMN). Apparently, the migration of PMN through the biofilms is impaired, and thus the bactericidal activity remains highly localized. The aim of this study was to directly investigate the interaction of PMN with the biofilm and the extracted extracellular polymeric substance (EPS) of P. aeruginosa.
Material and Methods
Chemotaxis and random migration of PMN through P. aeruginosa biofilms was tested, as was their migration through and along the EPS.
Results
We found that the EPS and mature biofilms, but not immature or developing ones, reduced the chemotactic migration of PMN. On EPS, rather than immobilize the cells, their random, spontaneous migration was enhanced.
Conclusion
We propose that on EPS, the PMN lose their capacity to sense the direction and just slide over the EPS in a disoriented manner. (Int J Artif Organs 2008; 31: 796–803)
CostertonJ.W., StewartP.S., GreenbergE.P.Bacterial biofilms: a common cause of persistent infections. Science1999; 284: 1318–22.
2.
HibyN., JohansenH.K., MoserC., SongZ., CiofuO., KharazmiA.Pseudomonas eruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect2001; 3: 23–35.
3.
ParsekM.R., SinghP.K.Bacterial biofilms: an emerging link to disease pathogenesis. Ann Rev Microbiol2003; 57: 677–701.
4.
DonlanR.Role of biofilms in antimicrobial resistance. ASAIO J2000; 46(Suppl): S47–52.
5.
DrenkardE.Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect2003; 13: 1213–19.
JensenE.T., KharazmiA., LamK., CostertonJ.W., HoibyN.Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa in biofilm. Infect Immun1990; 58: 2383–5.
8.
JesaitisA.J., FranklinM.J., BerglundD., SasakiM., LordC.I., BleazardJ.B., DuffyJ.E., BeyenalH., LewandowskiZ.Compromized host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol2003; 171: 4329–39.
9.
PedersenS.S., HoibyN., EspersenF., KochC.Role of alginate in infection with mucoid Pseudomonas eruginosa in cystic fibrosis. Thorax1992; 47: 6–13.
10.
GovanJ.R., DereticV.Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev1996; 60: 539–74.
11.
RamseyD.M., WozniakD.J.Understanding the control of Pseudomonas eruginosa alginate synthesis and the prospects for management of chronic cystic fibrosis. Mol Microbiol2005; 56: 309–22.
12.
WagnerC., KondellaK., BernschneiderT., HeppertV., WentzensenA., HänschG.M.Posttraumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection. Shock2003; 20: 503–10.
13.
WagnerC., ObstU., HänschG.M.Implant-associated osteomyelitis: collateral damage by the host defence?Int J Artif Organs2005; 28: 1172–80.
14.
GreenbergE.P.Bacterial communication and group behavior. J Clin Invest2003; 112: 1288–90.
15.
ZimmermannS., WagnerC., MüllerW., Brenner-WeissG., HugF., PriorB., ObstU., HänschG.M.Induction of neutrophil chemotaxis by the quorum-sensing molecule N-3-oxododecanoyl homoserine lactone (3OC12-HSL). Infect Immun2006; 74: 5687–92.
16.
WagnerC., ZimmermannS., Brenner-WeissG.The quorum-sensing molecule N-3-oxododecanoyl homoserine lactone (3=C12-HSL) enhances the host defence by activating human polymorphonuclear neutrophils (PMN). Anal Bioanal Chem2007; 481–7.
17.
VikströmE., MagnussonK-E, PivoriunsA.The Pseudomonas eruginosa quorum-sensing molecule N-(3-deoxydodecanoyl)-L-homoserine lactone stimulates phagocytic activity in human macrophages through the p38 MAPK pathway. Microbes Infect2005; 7: 1512–8.
18.
KharazmiA.Mechanisms involved in the evasion of the host defence by Pseudomonas eruginosa. Immunol Lett1991; 30: 201–6.
19.
WingenderJ., StrathmannM., RodeA., LeisA., FlemmingH-C. Isolation and biochemical characterization of extracellular polymeric substances from Pseudomonas eruginosa. Methods Enzymol2001; 336: 302–14.
20.
BrenneisH., SchmidtA., Blaas-MautnerP., WörnerI., LudwigR., HänschG.M.Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur J Clin Invest1993; 2: 693–8.
21.
KrallR., SchmidtG., AktoriesK., BarbieriJ.T.Pseudomonas eruginosa ExoT is a Rho GTPase-activating protein. Infect Immun2000; 68: 6066–8.
22.
Roy-BurmanA., SavelR.H., RacineS., SwansonB.L., RevadigarN.S., FujimotoJ., SawaT., FrankW., Wiener-KronischJ.P.Type III protein secretion is associated with death in the lower respiratory and systemic Pseudomonasa eruginosa infection. J Infect Dis2001; 183: 1767–74.
23.
PedersenS.S., KharazmiA., EspersenS., HoibyN.Pseudomonas eruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun1990; 58: 3363–8.
24.
HarakawaN., SasadaM., MedaA., AsagosK., NohgawaM., TakanoK., MatsudaY., YamamotoK., OkamaM.Random migration of polymorphonuclear leukocytes induced by GM-CSF involving a signal transduction pathway different from that of fMLP. J Leukoc Biol1997; 61: 500–6.
25.
Nakame-AkahoriM., KatoT., MasudaS., SakamotoE., HaruroK., FumikoH., YoshiiN., MasayukiH., KitagawaS.Enhanced neutrophil motility by granulocyte colony-stimulating factor: the role of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Immunology2006; 119: 393–403.
